Barry Littlejohns

2017

In 2017, Barry Littlejohns earned a total compensation of $1.3M as President, Drug Delivery Solutions at Catalent.

Compensation breakdown

Non-Equity Incentive Plan$355,559
Option Awards$132,003
Salary$448,571
Stock Awards$308,023
Other$22,664
Total$1,266,820

Littlejohns received $448.6K in salary, accounting for 35% of the total pay in 2017.

Littlejohns also received $355.6K in non-equity incentive plan, $132K in option awards, $308K in stock awards and $22.7K in other compensation.

Rankings

In 2017, Barry Littlejohns' compensation ranked 7,833rd out of 14,666 executives tracked by ExecPay. In other words, Littlejohns earned more than 46.6% of executives.

ClassificationRankingPercentile
All
7,833
out of 14,666
47th
Division
Manufacturing
2,937
out of 5,768
49th
Major group
Chemicals And Allied Products
955
out of 2,074
54th
Industry group
Drugs
742
out of 1,730
57th
Industry
Pharmaceutical Preparations
581
out of 1,329
56th
Source: SEC filing on September 22, 2017.

Littlejohns' colleagues

We found five more compensation records of executives who worked with Barry Littlejohns at Catalent in 2017.

2017

John Chiminski

Catalent

Chief Executive Officer

2017

Sharon Johnson

Catalent

Senior Vice President, Quality &Regulatory Affairs

2017

Matthew Walsh

Catalent

Chief Financial Officer

2017

William Downie

Catalent

Senior Vice President, Sales and Marketing

2017

Steven Fasman

Catalent

General Counsel

You may also like